カテゴリー： 世界, 医療/バイオ, LP Information

世界の硫酸モルヒネ注射市場予測 2023年-2029年

【英語タイトル】Global Morphine Sulfate Injection Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC01028）・商品コード：LP23DC01028
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：96
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の硫酸モルヒネ注射市場」は、過去の販売実績から2022年の世界の硫酸モルヒネ注射の総販売量を検討し、2023年から2029年の予測される硫酸モルヒネ注射の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の硫酸モルヒネ注射の市場規模を掲載し、XXX百万米ドル規模の世界の硫酸モルヒネ注射市場の詳細な分析を提供します。本インサイトレポートは、世界の硫酸モルヒネ注射業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の硫酸モルヒネ注射市場における各社の独自のポジションをより深く理解するために、硫酸モルヒネ注射製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の硫酸モルヒネ注射市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。硫酸モルヒネ注射の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。硫酸モルヒネ注射の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。硫酸モルヒネ注射のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

硫酸モルヒネ注射の世界主要メーカーとしては、Hameln Pharma、 Pfizer Inc.、 Piramal Pharma、 Fresenius Kabi、 Sterinova、 Nephron Pharmaceuticals、 Qinghai Pharmaceuticalなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の硫酸モルヒネ注射市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では硫酸モルヒネ注射市場をセグメンテーションし、種類別 (5 mg/ml 以下、 5-10 mg/ml、 10 mg/ml 以上)、用途別 (病院、クリニック、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：5 mg/ml 以下、 5-10 mg/ml、 10 mg/ml 以上

・用途別区分：病院、クリニック、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の硫酸モルヒネ注射市場の10年間の市場状況・展望は？
・世界および地域別に見た硫酸モルヒネ注射市場成長の要因は何か？
・硫酸モルヒネ注射の市場機会はエンドマーケットの規模によってどのように変化するのか？
・硫酸モルヒネ注射のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：硫酸モルヒネ注射の年間販売量2018-2029、地域別現状・将来分析
・硫酸モルヒネ注射の種類別セグメント：5 mg/ml 以下、 5-10 mg/ml、 10 mg/ml 以上
・硫酸モルヒネ注射の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・硫酸モルヒネ注射の用途別セグメント：病院、クリニック、その他
・硫酸モルヒネ注射の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の硫酸モルヒネ注射市場
・企業別のグローバル硫酸モルヒネ注射市場データ：2018-2023年の年間販売量、市場シェア
・企業別の硫酸モルヒネ注射の年間売上：2018-2023年の売上、市場シェア
・企業別の硫酸モルヒネ注射販売価格
・主要企業の硫酸モルヒネ注射生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

硫酸モルヒネ注射の地域別レビュー
・地域別の硫酸モルヒネ注射市場規模2018-2023：年間販売量、売上
・主要国別の硫酸モルヒネ注射市場規模2018-2023：年間販売量、売上
・南北アメリカの硫酸モルヒネ注射販売の成長
・アジア太平洋の硫酸モルヒネ注射販売の成長
・ヨーロッパの硫酸モルヒネ注射販売の成長
・中東・アフリカの硫酸モルヒネ注射販売の成長

南北アメリカ市場
・南北アメリカの国別の硫酸モルヒネ注射販売量、売上（2018-2023）
・南北アメリカの硫酸モルヒネ注射の種類別販売量
・南北アメリカの硫酸モルヒネ注射の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の硫酸モルヒネ注射販売量、売上（2018-2023）
・アジア太平洋の硫酸モルヒネ注射の種類別販売量
・アジア太平洋の硫酸モルヒネ注射の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の硫酸モルヒネ注射販売量、売上（2018-2023）
・ヨーロッパの硫酸モルヒネ注射の種類別販売量
・ヨーロッパの硫酸モルヒネ注射の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の硫酸モルヒネ注射販売量、売上（2018-2023）
・中東・アフリカの硫酸モルヒネ注射の種類別販売量
・中東・アフリカの硫酸モルヒネ注射の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・硫酸モルヒネ注射の製造コスト構造分析
・硫酸モルヒネ注射の製造プロセス分析
・硫酸モルヒネ注射の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・硫酸モルヒネ注射の主要なグローバル販売業者
・硫酸モルヒネ注射の主要なグローバル顧客

地域別の硫酸モルヒネ注射市場予測レビュー
・地域別の硫酸モルヒネ注射市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・硫酸モルヒネ注射の種類別市場規模予測
・硫酸モルヒネ注射の用途別市場規模予測

主要企業分析
Hameln Pharma、 Pfizer Inc.、 Piramal Pharma、 Fresenius Kabi、 Sterinova、 Nephron Pharmaceuticals、 Qinghai Pharmaceutical
・企業情報
・硫酸モルヒネ注射製品
・硫酸モルヒネ注射販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Morphine Sulfate Injection market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Morphine Sulfate Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Morphine Sulfate Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Morphine Sulfate Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Morphine Sulfate Injection players cover Hameln Pharma, Pfizer Inc., Piramal Pharma, Fresenius Kabi, Sterinova, Nephron Pharmaceuticals and Qinghai Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Morphine Sulfate Injection Industry Forecast” looks at past sales and reviews total world Morphine Sulfate Injection sales in 2022, providing a comprehensive analysis by region and market sector of projected Morphine Sulfate Injection sales for 2023 through 2029. With Morphine Sulfate Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Morphine Sulfate Injection industry.
This Insight Report provides a comprehensive analysis of the global Morphine Sulfate Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Morphine Sulfate Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Morphine Sulfate Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Morphine Sulfate Injection and breaks down the forecast by drug concentration, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Morphine Sulfate Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Morphine Sulfate Injection market by product drug concentration, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by drug concentration
Below 5 mg/ml
5-10 mg/ml
Above 10 mg/ml
Segmentation by application
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Hameln Pharma
Pfizer Inc.
Piramal Pharma
Fresenius Kabi
Sterinova
Nephron Pharmaceuticals
Qinghai Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Morphine Sulfate Injection market?
What factors are driving Morphine Sulfate Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Morphine Sulfate Injection market opportunities vary by end market size?
How does Morphine Sulfate Injection break out drug concentration, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Morphine Sulfate Injection Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Morphine Sulfate Injection by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Morphine Sulfate Injection by Country/Region, 2018, 2022 & 2029
2.2 Morphine Sulfate Injection Segment by Drug Concentration
2.2.1 Below 5 mg/ml
2.2.2 5-10 mg/ml
2.2.3 Above 10 mg/ml
2.3 Morphine Sulfate Injection Sales by Drug Concentration
2.3.1 Global Morphine Sulfate Injection Sales Market Share by Drug Concentration (2018-2023)
2.3.2 Global Morphine Sulfate Injection Revenue and Market Share by Drug Concentration (2018-2023)
2.3.3 Global Morphine Sulfate Injection Sale Price by Drug Concentration (2018-2023)
2.4 Morphine Sulfate Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Morphine Sulfate Injection Sales by Application
2.5.1 Global Morphine Sulfate Injection Sale Market Share by Application (2018-2023)
2.5.2 Global Morphine Sulfate Injection Revenue and Market Share by Application (2018-2023)
2.5.3 Global Morphine Sulfate Injection Sale Price by Application (2018-2023)
3 Global Morphine Sulfate Injection by Company
3.1 Global Morphine Sulfate Injection Breakdown Data by Company
3.1.1 Global Morphine Sulfate Injection Annual Sales by Company (2018-2023)
3.1.2 Global Morphine Sulfate Injection Sales Market Share by Company (2018-2023)
3.2 Global Morphine Sulfate Injection Annual Revenue by Company (2018-2023)
3.2.1 Global Morphine Sulfate Injection Revenue by Company (2018-2023)
3.2.2 Global Morphine Sulfate Injection Revenue Market Share by Company (2018-2023)
3.3 Global Morphine Sulfate Injection Sale Price by Company
3.4 Key Manufacturers Morphine Sulfate Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Morphine Sulfate Injection Product Location Distribution
3.4.2 Players Morphine Sulfate Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Morphine Sulfate Injection by Geographic Region
4.1 World Historic Morphine Sulfate Injection Market Size by Geographic Region (2018-2023)
4.1.1 Global Morphine Sulfate Injection Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Morphine Sulfate Injection Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Morphine Sulfate Injection Market Size by Country/Region (2018-2023)
4.2.1 Global Morphine Sulfate Injection Annual Sales by Country/Region (2018-2023)
4.2.2 Global Morphine Sulfate Injection Annual Revenue by Country/Region (2018-2023)
4.3 Americas Morphine Sulfate Injection Sales Growth
4.4 APAC Morphine Sulfate Injection Sales Growth
4.5 Europe Morphine Sulfate Injection Sales Growth
4.6 Middle East & Africa Morphine Sulfate Injection Sales Growth
5 Americas
5.1 Americas Morphine Sulfate Injection Sales by Country
5.1.1 Americas Morphine Sulfate Injection Sales by Country (2018-2023)
5.1.2 Americas Morphine Sulfate Injection Revenue by Country (2018-2023)
5.2 Americas Morphine Sulfate Injection Sales by Drug Concentration
5.3 Americas Morphine Sulfate Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Morphine Sulfate Injection Sales by Region
6.1.1 APAC Morphine Sulfate Injection Sales by Region (2018-2023)
6.1.2 APAC Morphine Sulfate Injection Revenue by Region (2018-2023)
6.2 APAC Morphine Sulfate Injection Sales by Drug Concentration
6.3 APAC Morphine Sulfate Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Morphine Sulfate Injection by Country
7.1.1 Europe Morphine Sulfate Injection Sales by Country (2018-2023)
7.1.2 Europe Morphine Sulfate Injection Revenue by Country (2018-2023)
7.2 Europe Morphine Sulfate Injection Sales by Drug Concentration
7.3 Europe Morphine Sulfate Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Morphine Sulfate Injection by Country
8.1.1 Middle East & Africa Morphine Sulfate Injection Sales by Country (2018-2023)
8.1.2 Middle East & Africa Morphine Sulfate Injection Revenue by Country (2018-2023)
8.2 Middle East & Africa Morphine Sulfate Injection Sales by Drug Concentration
8.3 Middle East & Africa Morphine Sulfate Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Morphine Sulfate Injection
10.3 Manufacturing Process Analysis of Morphine Sulfate Injection
10.4 Industry Chain Structure of Morphine Sulfate Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Morphine Sulfate Injection Distributors
11.3 Morphine Sulfate Injection Customer
12 World Forecast Review for Morphine Sulfate Injection by Geographic Region
12.1 Global Morphine Sulfate Injection Market Size Forecast by Region
12.1.1 Global Morphine Sulfate Injection Forecast by Region (2024-2029)
12.1.2 Global Morphine Sulfate Injection Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Morphine Sulfate Injection Forecast by Drug Concentration
12.7 Global Morphine Sulfate Injection Forecast by Application
13 Key Players Analysis
13.1 Hameln Pharma
13.1.1 Hameln Pharma Company Information
13.1.2 Hameln Pharma Morphine Sulfate Injection Product Portfolios and Specifications
13.1.3 Hameln Pharma Morphine Sulfate Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Hameln Pharma Main Business Overview
13.1.5 Hameln Pharma Latest Developments
13.2 Pfizer Inc.
13.2.1 Pfizer Inc. Company Information
13.2.2 Pfizer Inc. Morphine Sulfate Injection Product Portfolios and Specifications
13.2.3 Pfizer Inc. Morphine Sulfate Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Pfizer Inc. Main Business Overview
13.2.5 Pfizer Inc. Latest Developments
13.3 Piramal Pharma
13.3.1 Piramal Pharma Company Information
13.3.2 Piramal Pharma Morphine Sulfate Injection Product Portfolios and Specifications
13.3.3 Piramal Pharma Morphine Sulfate Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Piramal Pharma Main Business Overview
13.3.5 Piramal Pharma Latest Developments
13.4 Fresenius Kabi
13.4.1 Fresenius Kabi Company Information
13.4.2 Fresenius Kabi Morphine Sulfate Injection Product Portfolios and Specifications
13.4.3 Fresenius Kabi Morphine Sulfate Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Fresenius Kabi Main Business Overview
13.4.5 Fresenius Kabi Latest Developments
13.5 Sterinova
13.5.1 Sterinova Company Information
13.5.2 Sterinova Morphine Sulfate Injection Product Portfolios and Specifications
13.5.3 Sterinova Morphine Sulfate Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sterinova Main Business Overview
13.5.5 Sterinova Latest Developments
13.6 Nephron Pharmaceuticals
13.6.1 Nephron Pharmaceuticals Company Information
13.6.2 Nephron Pharmaceuticals Morphine Sulfate Injection Product Portfolios and Specifications
13.6.3 Nephron Pharmaceuticals Morphine Sulfate Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Nephron Pharmaceuticals Main Business Overview
13.6.5 Nephron Pharmaceuticals Latest Developments
13.7 Qinghai Pharmaceutical
13.7.1 Qinghai Pharmaceutical Company Information
13.7.2 Qinghai Pharmaceutical Morphine Sulfate Injection Product Portfolios and Specifications
13.7.3 Qinghai Pharmaceutical Morphine Sulfate Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Qinghai Pharmaceutical Main Business Overview
13.7.5 Qinghai Pharmaceutical Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Morphine Sulfate Injection Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Morphine Sulfate Injection Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Below 5 mg/ml
Table 4. Major Players of 5-10 mg/ml
Table 5. Major Players of Above 10 mg/ml
Table 6. Global Morphine Sulfate Injection Sales by Drug Concentration (2018-2023) & (K Units)
Table 7. Global Morphine Sulfate Injection Sales Market Share by Drug Concentration (2018-2023)
Table 8. Global Morphine Sulfate Injection Revenue by Drug Concentration (2018-2023) & ($ million)
Table 9. Global Morphine Sulfate Injection Revenue Market Share by Drug Concentration (2018-2023)
Table 10. Global Morphine Sulfate Injection Sale Price by Drug Concentration (2018-2023) & (US$/Unit)
Table 11. Global Morphine Sulfate Injection Sales by Application (2018-2023) & (K Units)
Table 12. Global Morphine Sulfate Injection Sales Market Share by Application (2018-2023)
Table 13. Global Morphine Sulfate Injection Revenue by Application (2018-2023)
Table 14. Global Morphine Sulfate Injection Revenue Market Share by Application (2018-2023)
Table 15. Global Morphine Sulfate Injection Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Morphine Sulfate Injection Sales by Company (2018-2023) & (K Units)
Table 17. Global Morphine Sulfate Injection Sales Market Share by Company (2018-2023)
Table 18. Global Morphine Sulfate Injection Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Morphine Sulfate Injection Revenue Market Share by Company (2018-2023)
Table 20. Global Morphine Sulfate Injection Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Morphine Sulfate Injection Producing Area Distribution and Sales Area
Table 22. Players Morphine Sulfate Injection Products Offered
Table 23. Morphine Sulfate Injection Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Morphine Sulfate Injection Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Morphine Sulfate Injection Sales Market Share Geographic Region (2018-2023)
Table 28. Global Morphine Sulfate Injection Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Morphine Sulfate Injection Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Morphine Sulfate Injection Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Morphine Sulfate Injection Sales Market Share by Country/Region (2018-2023)
Table 32. Global Morphine Sulfate Injection Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Morphine Sulfate Injection Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Morphine Sulfate Injection Sales by Country (2018-2023) & (K Units)
Table 35. Americas Morphine Sulfate Injection Sales Market Share by Country (2018-2023)
Table 36. Americas Morphine Sulfate Injection Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Morphine Sulfate Injection Revenue Market Share by Country (2018-2023)
Table 38. Americas Morphine Sulfate Injection Sales by Type (2018-2023) & (K Units)
Table 39. Americas Morphine Sulfate Injection Sales by Application (2018-2023) & (K Units)
Table 40. APAC Morphine Sulfate Injection Sales by Region (2018-2023) & (K Units)
Table 41. APAC Morphine Sulfate Injection Sales Market Share by Region (2018-2023)
Table 42. APAC Morphine Sulfate Injection Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Morphine Sulfate Injection Revenue Market Share by Region (2018-2023)
Table 44. APAC Morphine Sulfate Injection Sales by Drug Concentration (2018-2023) & (K Units)
Table 45. APAC Morphine Sulfate Injection Sales by Application (2018-2023) & (K Units)
Table 46. Europe Morphine Sulfate Injection Sales by Country (2018-2023) & (K Units)
Table 47. Europe Morphine Sulfate Injection Sales Market Share by Country (2018-2023)
Table 48. Europe Morphine Sulfate Injection Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Morphine Sulfate Injection Revenue Market Share by Country (2018-2023)
Table 50. Europe Morphine Sulfate Injection Sales by Type (2018-2023) & (K Units)
Table 51. Europe Morphine Sulfate Injection Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Morphine Sulfate Injection Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Morphine Sulfate Injection Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Morphine Sulfate Injection Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Morphine Sulfate Injection Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Morphine Sulfate Injection Sales by Drug Concentration (2018-2023) & (K Units)
Table 57. Middle East & Africa Morphine Sulfate Injection Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Morphine Sulfate Injection
Table 59. Key Market Challenges & Risks of Morphine Sulfate Injection
Table 60. Key Industry Trends of Morphine Sulfate Injection
Table 61. Morphine Sulfate Injection Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Morphine Sulfate Injection Distributors List
Table 64. Morphine Sulfate Injection Customer List
Table 65. Global Morphine Sulfate Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Morphine Sulfate Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Morphine Sulfate Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Morphine Sulfate Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Morphine Sulfate Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Morphine Sulfate Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Morphine Sulfate Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Morphine Sulfate Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Morphine Sulfate Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Morphine Sulfate Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Morphine Sulfate Injection Sales Forecast by Drug Concentration (2024-2029) & (K Units)
Table 76. Global Morphine Sulfate Injection Revenue Forecast by Drug Concentration (2024-2029) & ($ Millions)
Table 77. Global Morphine Sulfate Injection Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Morphine Sulfate Injection Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Hameln Pharma Basic Information, Morphine Sulfate Injection Manufacturing Base, Sales Area and Its Competitors
Table 80. Hameln Pharma Morphine Sulfate Injection Product Portfolios and Specifications
Table 81. Hameln Pharma Morphine Sulfate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Hameln Pharma Main Business
Table 83. Hameln Pharma Latest Developments
Table 84. Pfizer Inc. Basic Information, Morphine Sulfate Injection Manufacturing Base, Sales Area and Its Competitors
Table 85. Pfizer Inc. Morphine Sulfate Injection Product Portfolios and Specifications
Table 86. Pfizer Inc. Morphine Sulfate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Pfizer Inc. Main Business
Table 88. Pfizer Inc. Latest Developments
Table 89. Piramal Pharma Basic Information, Morphine Sulfate Injection Manufacturing Base, Sales Area and Its Competitors
Table 90. Piramal Pharma Morphine Sulfate Injection Product Portfolios and Specifications
Table 91. Piramal Pharma Morphine Sulfate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Piramal Pharma Main Business
Table 93. Piramal Pharma Latest Developments
Table 94. Fresenius Kabi Basic Information, Morphine Sulfate Injection Manufacturing Base, Sales Area and Its Competitors
Table 95. Fresenius Kabi Morphine Sulfate Injection Product Portfolios and Specifications
Table 96. Fresenius Kabi Morphine Sulfate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Fresenius Kabi Main Business
Table 98. Fresenius Kabi Latest Developments
Table 99. Sterinova Basic Information, Morphine Sulfate Injection Manufacturing Base, Sales Area and Its Competitors
Table 100. Sterinova Morphine Sulfate Injection Product Portfolios and Specifications
Table 101. Sterinova Morphine Sulfate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Sterinova Main Business
Table 103. Sterinova Latest Developments
Table 104. Nephron Pharmaceuticals Basic Information, Morphine Sulfate Injection Manufacturing Base, Sales Area and Its Competitors
Table 105. Nephron Pharmaceuticals Morphine Sulfate Injection Product Portfolios and Specifications
Table 106. Nephron Pharmaceuticals Morphine Sulfate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Nephron Pharmaceuticals Main Business
Table 108. Nephron Pharmaceuticals Latest Developments
Table 109. Qinghai Pharmaceutical Basic Information, Morphine Sulfate Injection Manufacturing Base, Sales Area and Its Competitors
Table 110. Qinghai Pharmaceutical Morphine Sulfate Injection Product Portfolios and Specifications
Table 111. Qinghai Pharmaceutical Morphine Sulfate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Qinghai Pharmaceutical Main Business
Table 113. Qinghai Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Morphine Sulfate Injection
Figure 2. Morphine Sulfate Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Morphine Sulfate Injection Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Morphine Sulfate Injection Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Morphine Sulfate Injection Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Below 5 mg/ml
Figure 10. Product Picture of 5-10 mg/ml
Figure 11. Product Picture of Above 10 mg/ml
Figure 12. Global Morphine Sulfate Injection Sales Market Share by Drug Concentration in 2022
Figure 13. Global Morphine Sulfate Injection Revenue Market Share by Drug Concentration (2018-2023)
Figure 14. Morphine Sulfate Injection Consumed in Hospital
Figure 15. Global Morphine Sulfate Injection Market: Hospital (2018-2023) & (K Units)
Figure 16. Morphine Sulfate Injection Consumed in Clinic
Figure 17. Global Morphine Sulfate Injection Market: Clinic (2018-2023) & (K Units)
Figure 18. Morphine Sulfate Injection Consumed in Others
Figure 19. Global Morphine Sulfate Injection Market: Others (2018-2023) & (K Units)
Figure 20. Global Morphine Sulfate Injection Sales Market Share by Application (2022)
Figure 21. Global Morphine Sulfate Injection Revenue Market Share by Application in 2022
Figure 22. Morphine Sulfate Injection Sales Market by Company in 2022 (K Units)
Figure 23. Global Morphine Sulfate Injection Sales Market Share by Company in 2022
Figure 24. Morphine Sulfate Injection Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Morphine Sulfate Injection Revenue Market Share by Company in 2022
Figure 26. Global Morphine Sulfate Injection Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Morphine Sulfate Injection Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Morphine Sulfate Injection Sales 2018-2023 (K Units)
Figure 29. Americas Morphine Sulfate Injection Revenue 2018-2023 ($ Millions)
Figure 30. APAC Morphine Sulfate Injection Sales 2018-2023 (K Units)
Figure 31. APAC Morphine Sulfate Injection Revenue 2018-2023 ($ Millions)
Figure 32. Europe Morphine Sulfate Injection Sales 2018-2023 (K Units)
Figure 33. Europe Morphine Sulfate Injection Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Morphine Sulfate Injection Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa Morphine Sulfate Injection Revenue 2018-2023 ($ Millions)
Figure 36. Americas Morphine Sulfate Injection Sales Market Share by Country in 2022
Figure 37. Americas Morphine Sulfate Injection Revenue Market Share by Country in 2022
Figure 38. Americas Morphine Sulfate Injection Sales Market Share by Drug Concentration (2018-2023)
Figure 39. Americas Morphine Sulfate Injection Sales Market Share by Application (2018-2023)
Figure 40. United States Morphine Sulfate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Morphine Sulfate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Morphine Sulfate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Morphine Sulfate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Morphine Sulfate Injection Sales Market Share by Region in 2022
Figure 45. APAC Morphine Sulfate Injection Revenue Market Share by Regions in 2022
Figure 46. APAC Morphine Sulfate Injection Sales Market Share by Drug Concentration (2018-2023)
Figure 47. APAC Morphine Sulfate Injection Sales Market Share by Application (2018-2023)
Figure 48. China Morphine Sulfate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Morphine Sulfate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Morphine Sulfate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Morphine Sulfate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Morphine Sulfate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Morphine Sulfate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Morphine Sulfate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Morphine Sulfate Injection Sales Market Share by Country in 2022
Figure 56. Europe Morphine Sulfate Injection Revenue Market Share by Country in 2022
Figure 57. Europe Morphine Sulfate Injection Sales Market Share by Drug Concentration (2018-2023)
Figure 58. Europe Morphine Sulfate Injection Sales Market Share by Application (2018-2023)
Figure 59. Germany Morphine Sulfate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Morphine Sulfate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Morphine Sulfate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Morphine Sulfate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Morphine Sulfate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Morphine Sulfate Injection Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Morphine Sulfate Injection Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Morphine Sulfate Injection Sales Market Share by Drug Concentration (2018-2023)
Figure 67. Middle East & Africa Morphine Sulfate Injection Sales Market Share by Application (2018-2023)
Figure 68. Egypt Morphine Sulfate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Morphine Sulfate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Morphine Sulfate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Morphine Sulfate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Morphine Sulfate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Morphine Sulfate Injection in 2022
Figure 74. Manufacturing Process Analysis of Morphine Sulfate Injection
Figure 75. Industry Chain Structure of Morphine Sulfate Injection
Figure 76. Channels of Distribution
Figure 77. Global Morphine Sulfate Injection Sales Market Forecast by Region (2024-2029)
Figure 78. Global Morphine Sulfate Injection Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Morphine Sulfate Injection Sales Market Share Forecast by Drug Concentration (2024-2029)
Figure 80. Global Morphine Sulfate Injection Revenue Market Share Forecast by Drug Concentration (2024-2029)
Figure 81. Global Morphine Sulfate Injection Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Morphine Sulfate Injection Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の硫酸モルヒネ注射市場予測 2023年-2029年] (コード：LP23DC01028)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の硫酸モルヒネ注射市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の硫酸アトロピン原薬市場予測 2023年-2029年
  • 世界の医薬品用硫酸サルブタモール市場予測 2023年-2029年
  • 世界のアルテスネイト注射市場予測 2023年-2029年
  • 世界のアシクロビル治療薬市場予測 2023年-2029年
  • 世界の塩酸オキシコドン徐放性薬剤市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆